AKT1 and melanoma: Straussman et al demonstrated the importance of stromal-derived mediators in melanoma resistance to PLX4720; the factor which correlated best with proliferation rescue was the MET ligand HGF, whose binding to MET resulted in activation of the MAPK and PI3K/Akt signaling pathways and resistance to MEK/RAF blocking (29).